01 1Aurobindo Pharma Limited
02 1Cipla Ltd.
03 1Esteve Quimica SA
04 1Gilead Alberta ULC
05 1HETERO LABS LIMITED
06 2Hetero Labs Limited
07 1Honour Lab Limited
08 1MSN Life Sciences Private Limited
09 1MYLAN LABORATORIES LIMITED
10 1Macleods Pharmaceuticals Limited
11 1Tianish Laboratories Private Limited
12 1YiChang HEC ChangJiang Pharmaceuical Co.,Ltd.
01 2TENOFOVIR ALAFENAMIDE FUMARATE
02 5Tenofovir Alafenamide Fumarate
03 2Tenofovir Alafenamide Hemifumarate
04 1Tenofovir Alafenamide Monofumarate
05 1Vemlidy
06 2tenofovir alafenamide fumarate
01 1China
02 9India
03 1Spain
04 2U.S.A
TENOFOVIR ALAFENAMIDE FUMARATE
NDC Package Code : 59651-483
Start Marketing Date : 2024-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
TENOFOVIR ALAFENAMIDE FUMARATE
NDC Package Code : 53104-7742
Start Marketing Date : 2024-04-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
TENOFOVIR ALAFENAMIDE FUMARATE
NDC Package Code : 57572-0040
Start Marketing Date : 2016-02-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TENOFOVIR ALAFENAMIDE FUMARATE
NDC Package Code : 54014-7340
Start Marketing Date : 2015-11-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TENOFOVIR ALAFENAMIDE FUMARATE
NDC Package Code : 49587-113
Start Marketing Date : 2019-06-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TENOFOVIR ALAFENAMIDE FUMARATE
NDC Package Code : 68554-0105
Start Marketing Date : 2016-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TENOFOVIR ALAFENAMIDE FUMARATE
NDC Package Code : 68554-0141
Start Marketing Date : 2016-11-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TENOFOVIR ALAFENAMIDE FUMARATE
NDC Package Code : 68554-0144
Start Marketing Date : 2016-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TENOFOVIR ALAFENAMIDE FUMARATE
NDC Package Code : 33342-510
Start Marketing Date : 2019-03-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
TENOFOVIR ALAFENAMIDE FUMARATE
NDC Package Code : 65015-877
Start Marketing Date : 2017-10-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Tenofovir Alafenamide Fumarate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tenofovir Alafenamide Fumarate, including repackagers and relabelers. The FDA regulates Tenofovir Alafenamide Fumarate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tenofovir Alafenamide Fumarate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tenofovir Alafenamide Fumarate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tenofovir Alafenamide Fumarate supplier is an individual or a company that provides Tenofovir Alafenamide Fumarate active pharmaceutical ingredient (API) or Tenofovir Alafenamide Fumarate finished formulations upon request. The Tenofovir Alafenamide Fumarate suppliers may include Tenofovir Alafenamide Fumarate API manufacturers, exporters, distributors and traders.
click here to find a list of Tenofovir Alafenamide Fumarate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tenofovir Alafenamide Fumarate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tenofovir Alafenamide Fumarate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tenofovir Alafenamide Fumarate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tenofovir Alafenamide Fumarate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tenofovir Alafenamide Fumarate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tenofovir Alafenamide Fumarate suppliers with NDC on PharmaCompass.
We have 11 companies offering Tenofovir Alafenamide Fumarate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
